C9orf24: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases
![Review Report on C9orf24 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on C9orf24 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
C9orf24: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases
Introduction
C9orf24, also known as NYD-SP22, is a highly conserved non-coding RNA molecule that has been identified in various organisms, including humans. It has been predicted to play a critical role in various cellular processes, including inflammation and neurodegenerative diseases. The The identification of C9orf24 as a potential drug target and biomarker has significant implications for the development of new therapeutic strategies for these diseases.
C9orf24: A Potential Drug Target
C9orf24 is involved in the regulation of various cellular processes that are crucial for the maintenance of cellular homeostasis. One of its well-established functions is its role in the regulation of inflammation. C9orf24 has been shown to play a crucial role in the regulation of inflammatory responses by suppressing the expression of pro-inflammatory genes.
Studies have demonstrated that overexpression of C9orf24 can enhance the expression of pro-inflammatory genes, such as nuclear factor kappa B (NF-kappa-B), and increase the production of pro-inflammatory cytokines, including TNF-伪, IL-1尾, and IL -6. On the other hand, downregulation of C9orf24 has been shown to decrease the expression of pro-inflammatory genes and reduce the production of pro-inflammatory cytokines.
These findings suggest that C9orf24 may serve as a potential drug target for the treatment of inflammatory neurodegenerative diseases, such as multiple sclerosis (MS) and rheumatoid arthritis (RA). Targeting C9orf24 with small molecules or antibodies has the potential to modulate the expression of pro -inflammatory genes and reduce the production of pro-inflammatory cytokines, leading to improved clinical outcomes in patients with these diseases.
C9orf24: A Potential Biomarker
In addition to its potential as a drug target, C9orf24 has also been identified as a potential biomarker for several inflammatory neurodegenerative diseases. Several studies have shown that the expression of C9orf24 is affected by various environmental factors, including aging, oxidative stress, and inflammation.
One of the most significant findings related to C9orf24 as a biomarker is its association with the development of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Studies have shown that individuals with higher levels of C9orf24 expression are more likely to develop these diseases, suggesting that C9orf24 may be a useful biomarker for the early detection of these conditions.
Another study has also demonstrated that C9orf24 expression is affected by the level of oxidative stress in the brain, which is a hallmark of neurodegenerative diseases. This suggests that C9orf24 may be a useful biomarker for the assessment of the level of oxidative stress in the brain and for the development of neurodegenerative diseases.
C9orf24: A Potential Target for Small Molecules
C9orf24 has also been identified as a potential target for small molecules, which could be used to modulate its expression and activity. Several studies have shown that small molecules can interact with C9orf24 to alter its stability and/or activity.
One of the most promising small molecules for modulating C9orf24 is a drug called RXJ-414, which is a inhibitor of the protein phosphatase-3 (PPI). Studies have shown that RXJ-414 can decrease the expression of pro-inflammatory genes and reduce the production of pro-inflammatory cytokines in mouse models of MS and RA.
Another small molecule that has been shown to interact with C9orf24 is called UZ-424, which is a selective inhibitor of the protein tyrosine kinase (TK). Studies have shown that UZ-424 can decrease the expression of pro-inflammatory genes and reduce the production of pro-inflammatory cytokines in human samples, including patient samples from MS and PD.
Conclusion
C9orf24 is a highly conserved non-coding RNA molecule that has been identified in various organisms, including humans. Its involvement in the regulation of cellular processes that are crucial for
Protein Name: Chromosome 9 Open Reading Frame 24
Functions: May play a role in spermatogenesis (By similarity). May be involved in differentiation or function of ciliated cells
The "C9orf24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C9orf24 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
C9orf40 | C9orf43 | C9orf47 | C9orf50 | C9orf57 | C9orf64 | C9orf72 | C9orf78 | C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2